clinical trials

Medicaid Mandate 2022: Striving for Equitable Access to Clinical Trials

Medicaid Mandate 2022: Striving for Equitable Access to Clinical Trials

Featured in Pharmaceutical Outsourcing, Scott Gray, CEO discusses changes to the Medicaid program and the impact it has on clinical trial participation. On Jan. 1, 2022, coverage of all “routine costs” associated with clinical trial participation became guaranteed for Medicaid beneficiaries through the Clinical Treatment Act. For clinical trial sponsors and clinical research organizations (CROs), …

Medicaid Mandate 2022: Striving for Equitable Access to Clinical Trials Read More »

Caring for rare: Celebrating Rare Disease Day 2023

Enhancing Patient Access and Retention in Rare Disease Clinical Trials

Featured in an article in PM360, Scott Gray, CEO, discusses new developments in the rare disease clinical trial industry ahead of the upcoming Rare Disease Day on February 28, 2022. Learn more about alleviating financial barriers to trial participation, mitigating geographical barriers to trial participation, and the federal efforts to support rare disease trials in …

Enhancing Patient Access and Retention in Rare Disease Clinical Trials Read More »

voice of the customer feedback

4 Ways to Drive Better Voice of the Customer Feedback

Featured in CMSwire, Alexis Lynch, Senior Marketing Manager, discusses the techniques Clincierge utilizes to gain insight into patient feedback and preferences in clinical trials. Companies are increasingly relying on feedback from Voice of the Customer (VoC) programs to deliver better service, improve marketing efforts, improve customer loyalty and provide faster customer resolution. The article explores …

4 Ways to Drive Better Voice of the Customer Feedback Read More »

Medicaid clinical trials routine costs

Medicaid Coverage of “Routine Costs” for Clinical Trials

Featured in Applied Clinical Trials, Scott Gray, CEO discusses changes to the Medicaid program and the impact it has on clinical trial participation. On Jan. 1, 2022, coverage of all “routine costs” associated with clinical trial participation became guaranteed for Medicaid beneficiaries through the Clinical Treatment Act. For clinical trial sponsors and clinical research organizations …

Medicaid Coverage of “Routine Costs” for Clinical Trials Read More »

Improving Access Pediatric Clinical Trial Participation

Improving Access for Pediatric Clinical Trial Participation

Featured in the winter edition of the SCRS InSite Journal, Scott Gray, CEO, discusses industry-wide challenges and key ways to alleviate emotional, financial, and logistical burdens to improve clinical trial access for pediatric patients and their caregivers. Alleviating burdens can boost trial recruitment, enhance the patient experience, and increase patient retention.

Practical Approach to Clinical Trial Diversity

A Practical Approach to Clinical Trial Diversity

In an article featured in BioProcess International, Scott Gray, CEO, discusses a practical approach to achieving inclusive representation in clinical studies. Life-science companies can attract large, diverse participant pools by reaching patients where they live, providing targeted and meaningful messaging about the benefits of trials and offering ongoing assistance.

rare disease trials patient support services

BioProcess International eBook: Patient Support for Rare Disease Trials

Download the eBook today! By providing direct support to participants from enrollment through the end of a clinical trial, logistics-management companies can help ease the financial, logistical, and psychological barriers to patient participation in rare disease trials. Such dedicated services can build trust between participants or caregivers and patient coordinators, improving the overall trial experience …

BioProcess International eBook: Patient Support for Rare Disease Trials Read More »

decentralized clinical trial hybrid clinical trial

COVID-19 and the Changing Landscape of Clinical Trials

 Featured in Applied Clinical Trials: Decentralized trials are the way of the future—yet it would be ill-advised to think of them as a one-size-fits-all solution. While the pandemic increased the industry’s acceptance of decentralized clinical trial protocols, moving to an entirely virtual model without in-person interaction is unrealistic. This sort of hybrid approach allows researchers …

COVID-19 and the Changing Landscape of Clinical Trials Read More »

Break barriers to clinical trial participation

Reducing Barriers to Participation in Clinical Trials for Rare Disease

Research teams who appreciate the unique needs of rare disease patients and invest in a white-glove approach on behalf of trial participants can reduce barriers to participation. For sponsors, clinical study teams, and site staff, this means easier patient recruitment at the beginning of a study and fewer dropouts throughout the duration of the trial—with …

Reducing Barriers to Participation in Clinical Trials for Rare Disease Read More »

Voice of the Patient Research

View the results of our recent research to explore how effective patient support strategies can reduce barriers, increase retention, and improve outcomes in rare disease clinical trials in our latest eBook.

Voice of the patient